These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 31032963)

  • 1. The percentage of high-grade prostatic adenocarcinoma in prostate biopsies significantly improves on Grade Groups in the prediction of prostate cancer death.
    Berney DM; Beltran L; Sandu H; Soosay G; Møller H; Scardino P; Murphy J; Ahmad A; Cuzick J;
    Histopathology; 2019 Oct; 75(4):589-597. PubMed ID: 31032963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of a contemporary prostate cancer grading system using prostate cancer death as outcome.
    Berney DM; Beltran L; Fisher G; North BV; Greenberg D; Møller H; Soosay G; Scardino P; Cuzick J
    Br J Cancer; 2016 May; 114(10):1078-83. PubMed ID: 27100731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contemporary Gleason Grading of Prostatic Carcinoma: An Update With Discussion on Practical Issues to Implement the 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma.
    Epstein JI; Amin MB; Reuter VE; Humphrey PA
    Am J Surg Pathol; 2017 Apr; 41(4):e1-e7. PubMed ID: 28177964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving the Rotterdam European Randomized Study of Screening for Prostate Cancer Risk Calculator for Initial Prostate Biopsy by Incorporating the 2014 International Society of Urological Pathology Gleason Grading and Cribriform growth.
    Roobol MJ; Verbeek JFM; van der Kwast T; Kümmerlin IP; Kweldam CF; van Leenders GJLH
    Eur Urol; 2017 Jul; 72(1):45-51. PubMed ID: 28162815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic importance of Gleason 7 disease among patients treated with external beam radiation therapy for prostate cancer: results of a detailed biopsy core analysis.
    Spratt DE; Zumsteg Z; Ghadjar P; Pangasa M; Pei X; Fine SW; Yamada Y; Kollmeier M; Zelefsky MJ
    Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):1254-61. PubMed ID: 23182392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gleason score 3 + 4=7 prostate cancer with minimal quantity of gleason pattern 4 on needle biopsy is associated with low-risk tumor in radical prostatectomy specimen.
    Huang CC; Kong MX; Zhou M; Rosenkrantz AB; Taneja SS; Melamed J; Deng FM
    Am J Surg Pathol; 2014 Aug; 38(8):1096-101. PubMed ID: 24832163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of the 2005 international society of urological pathology consensus conference on standard Gleason grading of prostatic carcinoma in needle biopsies.
    Billis A; Guimaraes MS; Freitas LL; Meirelles L; Magna LA; Ferreira U
    J Urol; 2008 Aug; 180(2):548-52; discussion 552-3. PubMed ID: 18550106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of Gleason score 3 + 4 = 7 prostate cancer with minimal amounts (<6%) vs ≥6% of Gleason pattern 4 tissue in needle biopsy specimens.
    Kır G; Seneldir H; Gumus E
    Ann Diagn Pathol; 2016 Feb; 20():48-51. PubMed ID: 26750655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors influencing disease progression of prostate cancer under active surveillance: a McGill University Health Center cohort.
    Barayan GA; Brimo F; Bégin LR; Hanley JA; Liu Z; Kassouf W; Aprikian AG; Tanguay S
    BJU Int; 2014 Dec; 114(6b):E99-E104. PubMed ID: 24684511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Percentage grade 4 tumour predicts outcome for prostate adenocarcinoma in needle biopsies from patients with advanced disease: 10-year data from the TROG 03.04 RADAR trial.
    Delahunt B; Steigler A; Atkinson C; Christie D; Duchesne G; Egevad L; Joseph D; Kenwright DN; Matthews J; Murray JD; Oldmeadow C; Samaratunga H; Spry NA; Thunders MC; Hondermarck H; Denham JW
    Pathology; 2022 Feb; 54(1):49-54. PubMed ID: 34955242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usual and unusual histologic patterns of high Gleason score 8 to 10 adenocarcinoma of the prostate in needle biopsy tissue.
    Gottipati S; Warncke J; Vollmer R; Humphrey PA
    Am J Surg Pathol; 2012 Jun; 36(6):900-7. PubMed ID: 22367295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of International Society of Urological Pathology (ISUP) grading for prostatic adenocarcinoma in thin core biopsies using TROG 03.04 'RADAR' trial clinical data.
    Delahunt B; Egevad L; Srigley JR; Steigler A; Murray JD; Atkinson C; Matthews J; Duchesne G; Spry NA; Christie D; Joseph D; Attia J; Denham JW
    Pathology; 2015 Oct; 47(6):520-5. PubMed ID: 26325671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SOCS3 Immunohistochemical Expression Seems to Support the 2005 and 2014 International Society of Urological Pathology (ISUP) Modified Gleason Grading System.
    Pierconti F; Martini M; Cenci T; Petrone GL; Ricci R; Sacco E; Bassi PF; Larocca LM
    Prostate; 2017 May; 77(6):597-603. PubMed ID: 28144985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome of Gleason 3 + 5 = 8 Prostate Cancer Diagnosed on Needle Biopsy: Prognostic Comparison with Gleason 4 + 4 = 8.
    Harding-Jackson N; Kryvenko ON; Whittington EE; Eastwood DC; Tjionas GA; Jorda M; Iczkowski KA
    J Urol; 2016 Oct; 196(4):1076-81. PubMed ID: 27265220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Should a Gleason score be assigned to a minute focus of carcinoma on prostate biopsy?
    Rubin MA; Dunn R; Kambham N; Misick CP; O'Toole KM
    Am J Surg Pathol; 2000 Dec; 24(12):1634-40. PubMed ID: 11117784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gleason scores in prostate needle biopsy and prostatectomy specimens in prostatic adenocarcinoma: A correlation study.
    Awang A; Md Isa N; Yunus R; Azhar Shah S; Md Pauzi SH
    Malays J Pathol; 2019 Dec; 41(3):253-257. PubMed ID: 31901909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gleason score 5 + 3 = 8 (grade group 4) prostate cancer-a rare occurrence with contemporary grading.
    Kryvenko ON; Williamson SR; Schwartz LE; Epstein JI
    Hum Pathol; 2020 Mar; 97():40-51. PubMed ID: 31923450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical outcome comparison of Grade Group 1 and Grade Group 2 prostate cancer with and without cribriform architecture at the time of radical prostatectomy.
    Hollemans E; Verhoef EI; Bangma CH; Rietbergen J; Roobol MJ; Helleman J; van Leenders GJLH
    Histopathology; 2020 Apr; 76(5):755-762. PubMed ID: 31944367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extended prostate biopsy scheme improves reliability of Gleason grading: implications for radiotherapy patients.
    King CR; McNeal JE; Gill H; Presti JC
    Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):386-91. PubMed ID: 15145152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dataset for the reporting of prostate carcinoma in core needle biopsy and transurethral resection and enucleation specimens: recommendations from the International Collaboration on Cancer Reporting (ICCR).
    Egevad L; Judge M; Delahunt B; Humphrey PA; Kristiansen G; Oxley J; Rasiah K; Takahashi H; Trpkov K; Varma M; Wheeler TM; Zhou M; Srigley JR; Kench JG
    Pathology; 2019 Jan; 51(1):11-20. PubMed ID: 30477882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.